Robbiani et al. [55] identified a convergent antibody cluster comprising six BCR sequences across three COVID-19 infected subjects that were experimentally validated to bind the SARS-CoV-2 spike protein receptor binding domain (RBD). The gene discussed is BCR; the disease is COVID-19.